InvestSMART

Creso Pharma Limited (ASX: CPH) - Announcements

- Current share price for CPH : $0.009

ASX company news and announcements for Creso Pharma Limited (CPH) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Creso Pharma Limited (CPH) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Creso Pharma Limited (CPH), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Creso Pharma Limited (CPH)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
- Creso to launch cannaQIX in Israel and the Middle East 2 Aug 2018 8:29AM $0.635 $0.009 fallen by 98.58%
- Quarterly Activities Report & Appendix 4C 31 Jul 2018 8:29AM $0.625 $0.009 fallen by 98.56%
- Appendix 3Y - Vesting of Performance Rights 30 Jul 2018 5:58PM $0.625 $0.009 fallen by 98.56%
- Cleansing Statement & Appendix 3B 27 Jul 2018 2:48PM $0.655 $0.009 fallen by 98.63%
- Entitlement Issue - Letter to Option holders 26 Jul 2018 6:26PM $0.675 $0.009 fallen by 98.67%
- Entitlement Issue - Letter to Ineligible Shareholders 26 Jul 2018 6:25PM $0.675 $0.009 fallen by 98.67%
- Entitlement Issue - Letter to Eligible Shareholders 26 Jul 2018 6:21PM $0.675 $0.009 fallen by 98.67%
- Appendix 3B 25 Jul 2018 7:05PM $0.700 $0.009 fallen by 98.71%
- Prospectus - Entitlement Issue 25 Jul 2018 6:19PM $0.700 $0.009 fallen by 98.71%
- Investor Presentation 25 Jul 2018 8:20AM $0.700 $0.009 fallen by 98.71%
- Appendix 3Y - Vesting of Performance Rights 23 Jul 2018 4:05PM $0.665 $0.009 fallen by 98.65%
- Conversion of Performance Rights & Appendix 3B 23 Jul 2018 3:58PM $0.665 $0.009 fallen by 98.65%
- Options Entitlement Issue 23 Jul 2018 3:28PM $0.665 $0.009 fallen by 98.65%
- Creso to finalise Colombian Acquisition 23 Jul 2018 8:36AM $0.650 $0.009 fallen by 98.62%
- Creso now trading on the Frankfurt Stock Exchange 17 Jul 2018 8:26AM $0.620 $0.009 fallen by 98.55%
- Appendix 3B 16 Jul 2018 6:12PM $0.620 $0.009 fallen by 98.55%
- Creso launches cannaQIX in New Zealand 2 Jul 2018 8:30AM n/a $0.009 n/a
- Creso JV launches infused terpene craft beers and beverages 25 Jun 2018 9:31AM $0.715 $0.009 fallen by 98.74%
- Creso welcomes decision to legalise Cannabis use in Canada 21 Jun 2018 8:30AM $0.685 $0.009 fallen by 98.69%
- Creso appoints Chief Operating Officer, Americas 14 Jun 2018 8:33AM $0.710 $0.009 fallen by 98.73%
- Licence to cultivate Medicinal Cannabis in Colombia granted 12 Jun 2018 8:28AM $0.720 $0.009 fallen by 98.75%
- Results of Meeting 31 May 2018 4:07PM $0.710 $0.009 fallen by 98.73%
- Update on Colombian Acquisition 31 May 2018 10:30AM $0.685 $0.009 fallen by 98.69%
- Commercial start of cannaQIX in BENELUX with first orders 21 May 2018 10:19AM $0.695 $0.009 fallen by 98.71%
- Creso expands into Israeli Medical Cannabis 16 May 2018 9:41AM $0.725 $0.009 fallen by 98.76%

701 - 725 of 891 results

Page 29 of 36

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.